Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model
{{output}}
The development of mucosal vaccines is crucial for controlling the transmission of respiratory viruses such as SARS-CoV-2 and influenza at their point of entry. This study aimed to validate a human tonsil-derived in vitro model for screening antigen formulatio... ...
